Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Canada"

Research Shows High Adherence to Performance Measures for RA Cohort

Arthritis Care & Research  |  June 7, 2018

New research examines the adherence rates for system-level performance measures in Canada. Using data from the Canadian Early Arthritis Cohort that spanned eight years, researchers determined the percentage of RA patients seen in yearly follow-up with the number of gaps between visits, the percentage of RA patients treated with a disease-modifying anti-rheumatic drug and number days from diagnosis to the initiation of treatment. The results: High adherence to system-level performance measures was found in this early RA cohort, with small declines in performance with the increasing length overtime…

Risankizumab Promising for Psoriasis; Plus Canada Approves Brodalumab

Michele B. Kaufman, PharmD, BCGP  |  March 21, 2018

Two Phase 3 clinical trials show that risankizumab is effective for achieving skin clearance in patients with psoriasis…

Lyme Disease Spreads Through Ontario

Lara C. Pullen, PhD  |  March 5, 2018

New research highlights the current geographic areas of Ontario, Canada, associated with Lyme disease and the presence of Ixodes scapularis. The study found the ticks are expanding their range at a rate of 46–55 km/year, with several sites showing the presence of Borrelia burgdorferi, which causes Lyme disease. These findings may help target public health interventions in the areas at greatest risk…

Advances in Education for Rheumatology Health Professionals: A Review & an Opportunity

Courtesy of the ARHP Practice Committee  |  September 22, 2017

Educational opportunities for health professionals are expanding. At this year’s Annual Meeting, don’t miss a historic joint session from the ARHP and the Canada-based Arthritis Health Professions Association about the advances in and effects of these educational opportunities on rheumatology…

Opioid Investigated to Treat Acute & Chronic OA Pain; Plus New RA Treatment & More

Michele B. Kaufman, PharmD, BCGP  |  January 20, 2016

In Phase 2 trials, the oral opioid, CR845, has proved promising in treating pain in patients with hip and knee osteoarthritis. Olokizumab is being investigated to treat RA, and in Canada, adalimumab has been approved to treat polyarticular JIA in 2–4 year-olds…

Pharmacy-based Arthritis Screening Debuts in Canada

Kurt Ullman  |  February 1, 2014

Co-sponsored program between the Ministry of Health and pharmacy chain tasks pharmacists with screening people for knee osteoarthritis

  • « Previous Page
  • 1
  • 2
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences